Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Randomized Study in Patients With Colorectal Cancer With Unresectable Metastases. Impact of Resection vs no Resection of the Primary Tumour as a Survival Factor

NCT02015923 is registered in ClinicalTrials.gov with Hospital Universitari de Bellvitge as lead sponsor.

NCT NCT02015923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02015923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Randomized Study in Patients With Colorectal Cancer With Unresectable Metastases. Impact of Resection vs no Resection of the Primary Tumour as a Survival Factor
Lead sponsor
Hospital Universitari de Bellvitge
Phase
Phase 4
Overall status
Terminated
Start date
December 31, 2013
Completion date
February 29, 2020
Enrollment
107 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

colonic cancer, unresectable metastasis originating in colonic cancer